NCT00197301View on ClinicalTrials.gov

Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Vaccination

Trial Locations (1)

91120

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT00197301 - Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy | Biotech Hunter | Biotech Hunter